Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Research confirms important differences in colorectal cancer patients with a history of Inflammatory Bowel Disease

IBD-associated colorectal cancers were found to occur in younger patients and have worse outcomes. Researchers call for urgent improvement of early detection methods to provide more risk-based and personalised care.

Colon cancer image. Cancer attacking cell

Inflammatory bowel diseases (IBDs) are associated with an increased risk of developing colorectal (bowel) cancer (CRC). 

Published last month in the American Journal of Gastroenterology, research co-authored by Professor Eva Morris (Nuffield Department of Population Health) reveals key differences between patients with CRC and those with IBD-related CRC (IBD-CRC).

In what is believed to be the largest such study to date, the research draws on population data from the NHS to compare the symptoms and outcomes of all 390,614 UK cases of CRC with and without a prior diagnosis of IBD between 2005 and 2018.’ 

Read the news story on the Oxford Cancer website

 



Similar stories